News for Globus Medical, Inc. (GMED)

Summary Globus Medical Inc (GMED), a prominent player in the musculoskeletal technology sector, has announced that it will release its financial results for the

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (:GMED), a leading musculoskeletal technology company, will announce its financial resul

Globus Medical (GMED) to release first quarter 2025 earnings on May 8, 2025. The earnings call will be held at 4:30 p.m. Eastern Time on the same day.

BTIG has adjusted its forecast for Globus Medical (GMED), reducing the price target from $94 to $88, while maintaining a Buy rating on the stock. This revision

Truist Securities has revised its price target for Globus Medical (GMED) from $82 to $80 while maintaining a Hold rating on the company's shares. This adjustmen

On April 3, 2025, Globus Medical Inc (GMED), a prominent musculoskeletal technology company, announced the successful completion of its acquisition of Nevro Cor

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announce...

GMED stays on investors' radar due to its high NuVasive-merger synergies and solid Musculoskeletal prospects.

GMED announces the commercial launch of COHERE ALIF Spacer and Modulus ALIF Blades.

Shares of Globus Medical Inc (GMED) fell 3.14% in mid-day trading on Mar 12. The stock reached an intraday low of $70.62, before recovering slightly to $71.18

**media[563784]**

**media[559702]**

**media[558526]**

Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Globus Medical, Inc.

PR NewswireREDWOOD CITY, Calif., March 4, 2025 REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device compan

The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment.

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

PR NewswireMILWAUKEE, Feb. 24, 2025 MILWAUKEE, Feb. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Nevro (NYSE: NVRO) for possible breaches of fi